Volume : 10, Issue : 12, December – 2023
Title:
EVALUATION OF IBUPROFEN – IN SELF EMULSIFYING DRUG DELIVERY SYSTEM
Authors :
Mr.S. Mohankumar, S. Gokulakannan, G. Gothishwari, E. Gowtham, N. Hariharan, JP. Haritha
Abstract :
SEDDS (Self Emulsifying Drug Delivery System) is an isotropic mixture of oil, surfactant, solvent and co -solvent/surfactants that can be used to design formulations for oral administration of highly lipophilic drugs. SEDDS can be administered orally in soft/hard gelatin capsules. SEDDS form fine (or micro) emulsions in GIT with mild gastric agitation. Many parameters such as surfactant concentrations, oil / surfactant ratio, emulsion polarity and droplet size/charge play an important role in oral drug absorption from SEDDS. This formulation improves bioavailability by increasing drug solubility and minimizes gastric irritation due to the hydrophobic nature of nearly 40% of new drug compounds.This formulation can be used to enhance oral absorption of drugs that are not soluble orally, such as Ibuprofen. The purpose of this study is to formulate SEDDS for Ibuprofen and to evaluate its anti inflammatory properties in vitro and in vivo. The following evaluations were performed on the SEDDS formulations: Visual Isotropicity, Emulsification Time, Drug Content, In vitro Drug Release, Post Dilution Drug Precipitation, and In vivo Anti Inflammation Testing. All batches passed the Visual Isotropic test, Emulsification time was less than 1 minute, and the drug release was rapid. Infinite Aqueous Dilution showed no Phase separation and no phase separation. In vivo anti inflammatory studies showed significantly higher anti inflammatory activity (p <0.05). Ibuprofen powder
Cite This Article:
Please cite this article in press G.Gothishwari et al, Evaluation Of Ibuprofen – In Self Emulsifying Drug Delivery System, Indo Am. J. P. Sci, 2023; 10 (12)..
Number of Downloads : 10
References:
1. Tang JL,Sun J,He ZG. (Self-Emulsifying Drug Delivery Systems: Strategy for improving Oral Delivery of Poorly Soluble Drugs). Current Drug Therapy, 2007; 2(1): 85-93.
2. Charman SA, Charman WN, Rogge MC, Wilson TD, Proton CE. (Self-Emulsifying Drug Delivery Systems: formulation and biopharmaceutical evaluation of an investigational lipophilic compound). Pharm Research, 1992; 9: 87-93.
3. Craig GM, Lievens SR, Strorey DE. (An investigation into the physicochemical properties of self emulsifying systems using low frequency dielectric spectroscopy, suface tension measurements and particle size analysis). Int. j. Pharm, 1993; 96: 147- 155.
4. Erica F, Dario V, Mario G ,Beatrice F, Jelena F, Francesco M. (Self-emulsifying pellet prepared by wet granulation in high shear mixer: Influence of formulation variables and preliminary study on the invitro absorption). Int.J.Pharm, 2005; 291: 87-97.
5. Obitte NC, Ezeiruaku H, Onyishi VI. (Preliminary studies on two Vegetable Oil Based self-Emulsifying Delivery System (SEDDS) for the delivery of Metronidazole, a poorly water soluble Drug). Journal of Applied Science, 2008; 8 (10): 1950-1955.
6. Bajaj H, Bisht S, Yadav M, Singh V, Singh M (2011). (Self-Emulsifying Drug Delivery System: An approach to enhance bioavailability). International Journal of Pharma. Research and Development, 2011; 3(1): 59-75.
7. Amidon, G, et.al. (A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability). Pharm. Res, 1995; 12: 413-420.
8. Constantides PP. (Lipid Microemulsion for improving dissolution and oral absorption: physical and bio pharmaceutical aspects). Pharm Res, 1995; 12: 56 – 72.
9. Patel PA, Chaulang GM, Akolkothar A, Mutha SS, Hardikar SR, Bhosale AV. (Self-Emulsifying Drug Delivery System: A Review). Research J. Pharm and Tech, 2008; 1(4):313-323.
10. Obitte NC, Amarauche C. (The excipient usefulness of carbosil® and Landolphia owariensis in two oil-based self-emulsifying formulations). Asian Journal of Pharmaceutics, 2011; 4(4): 213- 219.
11. Obitte NC, Rohan LC, Adeyeye CM, Esimone CO. (Optimized Artemether loaded Anhydrous Emulsion). British Journal of Pharmaceutical Research, 2014; 4(1):37-59.
12. Winter CA, Risley EA, Nuss GW. (Anti-inflammatory and antipyretic activities of Indomethacin 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid).J Pharmacol Exp Ther, 1963; 141:369-76.
13. Perez GR. (Anti-inflammatory activity of Ambrosia artemisiaefolia and Rheo spathaceae). Phytomedicine, 1996; 3: 163-4.
14. Obitte NC, Ofokansi KC, Chime SA, Idike E. (Solid self-emulsifying drug delivery system based homolipid and vegetable oil: A potential vehicle for the delivery of indomethacin a disadvantaged drug). Int J Green Pharmacy, 2013; 7: 244 – 251.
15. Pouton CW. (Self-emulsifying Drug Delivery systems: Assessment of the efficiency of emulsification). International Journal of Pharmaceutics, 1985; 27:335-348.
16. Pouton CW. (Efects of inclusion of a model drug on the performance of self-emulsifying formulation). Journal of pharmacy and Pharmacology, 1985; 37 (1): 1-11.
17. 18. Khoo SM, Humberstone CJ, Porter H, Edwards GA. (Formulation design and Bioavailability assessment of Lipid Self Emulsifying Formulations of Halofantrine). Intn.J. Pharm, 1998; 167(1):155-164.
18. 19. Holm R, Porter CJH, Mullert A, Kristensen, HG, Chairman, WN. Structured triglyceride vehicles for oral delivery of halofantrine: halofantrine in two different self-micro emulsifying drug examination of intestinal lymphatic transport and bioavailability in delivery systems based on a structured triglyceride, con- conscious rats. Pharm. Res, 2002; 19: 1354–1361.
19. 20. O’Driscoll CM. (Lipid-based formulations for intestinal lymphatic delivery).Eur. J. Pharm. Sci, 2002; 15: 405–41